-
Our
#metabolomics paper to identify early predictors of#T2D has been featured in@NatureRevEndo. https://www.nature.com/articles/s41574-018-0045-x … Kudos to our#Framingham team! https://link.springer.com/article/10.1007%2Fs00125-018-4599-x …@DiabetologiaJnl@EASDnews@MGH_RIpic.twitter.com/h6UvmTXq2H
-
This is so painfully obvious to anyone who has dared to try another way out of the "throw drugs at it" approach to medicine.
#insulinresistance#lchf#t2d https://www.cnbc.com/2018/06/20/diabetes-defeated-by-diet-new-fresh-food-prescriptions-beat-drugs.html?mc_cid=f10bf73a8a&mc_eid=10cdcf89f0 …@ProfTimNoakes -
Thanks all for sharing your experiences of life with type 1 and type 2 diabetes with us! Your input is so valuable! Come join us again soon
#T1D#T2D pic.twitter.com/CnuoPpSUP4
-
2018 ADA Conference: Diabetes Technology Stars https://www.healthline.com/diabetesmine/ada-scientific-sessions-2018-products …
#Afrezza#InhaledInsulin#Diabetes#T1D#T2D#Innovation#GlucoseControl#BloodSugarpic.twitter.com/pd5X7hKjKl
-
-
Prof Roy Taylor & I both agreed today on how important it is to be clear what we mean by
#T2D remission and that as a concept it is aspirational -representing as it does hope for people with T2 Diabetes@APPG_Diabetes@Diabetescouk@DiabetesUK@DietDoctor1@fixingdad@fgodleepic.twitter.com/VOh1idqrfl
-
Join the
's largest diabetes community. There are over 270,901 forum members!
With over 100,000 discussions and 1.5 million posts you are bound something to get involved with! #GBDoc#T1D#T2D Find support, ask questions and share your experiences - https://bit.ly/2HoqLrw pic.twitter.com/M8NsSLSTJR -
FINALLY this e-learning module live! The very FIRST module on
#diabetes the@rcgp has created with@Diabetescouk - I’m so glad it sets the focus on patient empowerment and#T2D remission. Now every GP can get access to this valuable information from an esteemed source.

pic.twitter.com/ib6y5Zx5lH
-
#Wholegrains are intergral to a healthy, balanced diet but intake in the UK is low. Read the new Nutrition Bulletin paper (June 2018) 'The challenge of increasing wholegrain intake in the UK' here: https://onlinelibrary.wiley.com/doi/10.1111/nbu.12319 …#WholeGrain4Health#T2D#CVD#colorectalcancer@wcrfintpic.twitter.com/AoWOBGX1lq
-
Full Throttle Basketball | Train to Dominate
#T2D -
Fabulous speakers on SGLT2i in
#T1D at#2018ADA to close the conference. J Rosenstock asks if we should look at SGLT2i effect on CVD in#T1D as we have one in#T2D pic.twitter.com/YGjPnsRuvo
-
New results from
@NIDDKgov-funded@RISEstudy: Two#diabetes medications don’t slow the progression of type 2 diabetes in youth https://www.nih.gov/news-events/news-releases/two-diabetes-medications-dont-slow-progression-type-2-diabetes-youth …#T2D#2018ADA#RISEstudypic.twitter.com/gjV4lDiwi8
Deze collectie tonen -
.
@virtahealth ‘s@amymckenzie_phd on pre-diabetes at#2018ADA. At 1 yr, 61% regression to normal glycemic, 0% progression to#T2D pic.twitter.com/Ef8j3Oha0V
Deze collectie tonen -
Poster 1142, with eGGR ~78, A1c 7.8, sitagliptin more potent in A1c lowering in
#t2d#ADA2018pic.twitter.com/GJVWNIxAmm
-
Congrats to my lil bro Jordan Walsh (c/o 2022) for taking care of business at MADEhoops National Camp this week in Brooklyn. Made the top 20 All Star game.
#T2D Kid is going to be scary good! pic.twitter.com/deLO82Fvpo
-
“Our team are excited and motivated to help people with diabetes through our education platform. We can’t wait to work with Ascensia”explains Rich Lanchantin from
@Qstream demos their solution for#t2d#diabetes from the#Ascensia#DiabetesChallengepic.twitter.com/NKfO0e6lpQ
-
Gerry Shulman in the Banting lecture firmly restates his long standing belief that
#insulinresistance is the primary cause of#T2D https://www.jci.org/articles/view/77812 … Long controversial-for a genetics perspective see lecture at noon today#2018ADA from@markmccarthyoxfpic.twitter.com/NXw626XkLe
-
Afrezza - Significantly reduced the time spent in hypoglycemia (i.e., <70 mg/dl) by 41% or approximately 23 minutes per day http://www.globenewswire.com/news-release/2018/06/23/1528571/0/en/MannKind-Presents-Positive-Afrezza-Clinical-Data-from-STAT-and-AFFINITY-Studies-at-ADA-78th-Scientific-Sessions.html …
#2018ADA#Diabetes#Innovation#T1D#T2D#FastInFastOut#InhaledInsulin#Insulinpic.twitter.com/oVBDzUlpmc
-
9 out of 10 users that try Afrezza Inhaled Insulin are amazed at it's onset of action & gentle landings. It's the fastest, safest insulin made...
#FastInFastOut#2018ADA#T1D#T2D#Diabetes#Innovation#Technology https://www.instagram.com/p/BkW62bWAlph pic.twitter.com/C2e168khiB
Het laden lijkt wat langer te duren.
Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.